Compare EBS to:
After Hours:
13.97
-0.43 (-2.99%) 7:53pm ET
| Last Trade: | 14.40 |
|---|---|
| Trade Time: | 4:05pm ET |
| Change: | |
| Prev Close: | 14.53 |
| Open: | 14.54 |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 21.40 |
| Day's Range: | 14.20 - 14.56 |
|---|---|
| 52wk Range: | 9.15 - 27.00 |
| Volume: | 257,702 |
| Avg Vol (3m): | 307,386 |
| Market Cap: | 443.49M |
| P/E (ttm): | 15.91 |
| EPS (ttm): | 0.91 |
| Div & Yield: | N/A (N/A) |
| Mon 8:37pm | HHS Cancels RFP for rPA Procurement and Modifies Their Approach in Favor of BAA for Development of rPA VaccinesBusiness Wire |
| Thu, Dec 3 | Prospecting for Winning Biotechs: Gilead Sciencesat Motley Fool |
| Wed, Dec 2 | Yes, Virginia, There Are Bullish Speculatorsat Forbes.com |
| Tue, Dec 1 | Former U.K. Health Protection Agency Director Rejoins Emergent BioSolutions to Head Biodefense BusinessBusiness Wire |
| Mon, Nov 30 | Emergent BioSolutions to Webcast Presentations at Upcoming Investor ConferencesBusiness Wire |
| Mon, Nov 23 | Corporate Profile Emergent BioSolutions Inc.WILink |
| Thu, Nov 19 | Md. gov announces biopharmaceutical firm's growthAP |
| Fri, Nov 13 | Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in BaltimoreBusiness Wire |
| Wed, Nov 11 | EMERGENT BIOSOLUTIONS INC. FinancialsEDGAR Online Financials |
| Sun, Nov 8 | New Star Analyst Rankings for EMERGENT BIOSOLUTIONStarMine |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.